Opioid Lawsuit Targets Purdue Family and President as Defendants

Explosive allegations revealed in Massachusetts AG lawsuit.

Massachusetts is one of 36 states suing Purdue Pharma, maker of the addictive opioid pain medication OxyContin, for deceiving doctors and patients in the sale of the drug.

Yet the Massachusetts lawsuit is unique in that it is the first to sue not only Purdue Pharma, which is owned by the Sackler family, but also eight members of the Sackler family themselves who served on the Purdue Board or as company executives, including former Purdue President Richard Sackler. 

The case made news late last week when Massachusetts Superior Court Judge Janet Sanders granted a motion filed by a consortium of major news outlets, including Reuters, The Boston Globe, and The New York Times, to reveal large portions of the 274-page amended complaint that had been heavily redacted. Judge Sanders rejected Purdue’s argument that she should wait to see how a special master in charge of discovery handles similar arguments being made in federal court in Ohio, where a multidistrict litigation against Purdue on behalf of several other states, counties, cities, and tribes is playing out. 

The newly released portions of the Massachusetts Attorney General’s complaint contain many explosive allegations highlighting the degree to which the Sackler family defendants allegedly micromanaged the Purdue business, as well as the family’s rapacious greed and disregard for patient welfare. The following are some of the more notable allegations:

  • In 2009, Purdue hired McKinsey to help shape its message for selling OxyContin and overcome rising concerns about addiction and overdoses. Among the McKinsey recommendations Purdue allegedly adopted was an intense push in 2013 to have its sales representatives increase their sales visits to high-prescribing doctors. McKinsey recommended that targeting the most frequent prescribers could boost OxyContin sales by hundreds of millions of dollars. As quotas rose, the complaint alleges, so did the total visits.      
         
  • “Purdue Pharma created the epidemic and profited from it through a web of illegal deceit. First, Purdue deceived Massachusetts doctors and patients to get more and more patients on its dangerous drugs. Second, Purdue misled them to use higher and more dangerous doses. Third, Purdue deceived them to stay on the drugs for longer and more harmful periods of time. All the while, Purdue peddled falsehoods to keep patients away from safer alternatives. Even when Purdue knew people in Massachusetts were addicted and dying, Purdue treated doctors and their patients as targets to sell more drugs. At the top of Purdue, a small group of executives led the deception and pocketed millions of dollars.” -First Amended Complaint, Paragraph 2.
  • Purdue failed to act on information it had about doctors suspected of abusing or illegally prescribing OxyContin. In 2012, the complaint alleges, Purdue rejected one of its employee’s requests to its head of sales that Purdue notify health insurers about this list of suspect doctors, which was code-named “Project Zero.”
  • Both the Massachusetts lawsuit and the multidistrict litigation in federal court in Ohio are being played out in the context of a 2007 move in which Purdue pleaded guilty to a felony and agreed to stop mispresenting OxyContin’s addictive properties; two of its executives, former CEO Michael Friedman and former legal counsel Howard Udell, also pleaded guilty to a misdemeanor for misbranding OxyContin. In her amended complaint, Massachusetts Attorney General Maura Heeley notes that no Sackler family members pleaded guilty in 2007, and suggests instead that as a way of buying their loyalty and silence, Purdue paid Udell $6 million between 2008 and 2009 and paid Friedman $3 million in 2008.  

The Massachusetts case is in its early stages.  Purdue has filed a motion challenging Massachusetts as an appropriate jurisdiction for this action, which has yet to be heard. We will continue to monitor the cases against Purdue in both Massachusetts state court and Ohio federal court as they develop.     

Comment on this article

Facebook
Twitter
LinkedIn

Mary Inman, Esq.

Mary Inman is a partner and co-founder of Whistleblower Partners LLP, a law firm dedicated to representing whistleblowers under the various U.S. whistleblower reward programs. Mary and her colleagues have pioneered a series of successful whistleblower cases against prominent health insurers, hospitals, provider groups, and vendors under the False Claims Act alleging manipulation of the risk scores of Medicare Advantage patients. Mary is a recognized expert and frequent author, commentator, and speaker on frauds in the healthcare industry, particularly those exposed by whistleblowers. Mary is a member of the RACmonitor editorial board and a popular panelist on Monitor Monday.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

Stop revenue leakage and boost hospital performance by mastering risk adjustment and HCCs. This essential webcast with expert Cheryl Ericson, RN, MS, CCDS, CDIP, will reveal how inaccurate patient acuity documentation leads to lost reimbursements through penalties from poor quality scores. Learn the critical differences between HCCs and traditional CCs/MCCs, adapt your CDI workflows, and ensure accurate payments in Medicare Advantage and value-based care models. Perfect for HIM leaders, coders, and CDI professionals.  Don’t miss this chance to protect your hospital’s revenue and reputation!

May 29, 2025
I050825

Mastering ICD-10-CM Coding for Diabetes and it’s Complications: Avoiding Denials & Ensuring Compliance

Struggling with ICD-10-CM coding for diabetes and complications? This expert-led webcast clarifies complex combination codes, documentation gaps, and sequencing rules to reduce denials and ensure compliance. Dr. Angela Comfort will provide actionable strategies to accurately link diabetes to complications, improve provider documentation, and optimize reimbursement—helping coders, CDI specialists, and HIM leaders minimize audit risks and strengthen revenue integrity. Don’t miss this chance to master diabetes coding with real-world case studies, key takeaways, and live Q&A!

May 8, 2025

Trending News

Featured Webcasts

Medicare Advantage 2026: Navigating New Rules, Denial Protections & SDoH Shifts

Medicare Advantage 2026: Navigating New Rules, Denial Protections & SDoH Shifts

Stay ahead of Medicare Advantage’s 2025-2026 regulatory changes in this critical webcast featuring expert Tiffany Ferguson, LMSW, CMAC, ACM. Learn how new CMS rules limit MA plan denials, protect hospitals from retroactive claim reopenings, and modify Two-Midnight Rule enforcement—plus key insights on omitted SDoH mandates and heightened readmission scrutiny. Discover actionable strategies to safeguard revenue, ensure compliance, and adapt to evolving health equity priorities before the June 2025 deadline. Essential for hospitals, revenue cycle teams, and compliance professionals navigating MA’s shifting landscape.

May 28, 2025
Navigating the 3-Day & 1-Day Payment Window: Compliance, Billing, and Revenue Protection

Navigating the 3-Day & 1-Day Payment Window: Compliance, Billing, and Revenue Protection

Struggling with CMS’s 3-Day Payment Window? Join compliance expert Michael G. Calahan, PA, MBA, CCO, to master billing restrictions for pre-admission and inter-facility services. Learn how to avoid audit risks, optimize revenue cycle workflows, and ensure compliance across departments. Critical for C-suite leaders, providers, coders, revenue cycle teams, and compliance teams—this webcast delivers actionable strategies to protect reimbursements and meet federal regulations.

May 15, 2025
Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Providers face increasing Medicare audits when using skin substitute grafts, leaving many unprepared for claim denials and financial liabilities. Join veteran healthcare attorney Andrew B. Wachler, Esq., in this essential webcast and master the Medicare audit process, learn best practices for compliant billing and documentation, and mitigate fraud and abuse risks. With actionable insights and a live Q&A session, you’ll gain the tools to defend your practice and ensure compliance in this rapidly evolving landscape.

April 17, 2025
Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Dr. Ronald Hirsch dives into the basics of Medicare for clinicians to be successful as utilization review professionals. He’ll break down what Medicare does and doesn’t pay for, what services it provides and how hospitals get paid for providing those services – including both inpatient and outpatient. Learn how claims are prepared and how much patients must pay for their care. By attending our webcast, you will gain a new understanding of these issues and be better equipped to talk to patients, to their medical staff, and to their administrative team.

March 20, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24